- Postmenopausal osteoporosis
- Glucocorticoid-induced osteoporosis
OSTERI
| MRP | : |
|
| Price | : | ₹5,000.00 |
| You Save | : | ₹5,170.00Â (50.84%) |
1 prefilled syringe
Osteri 600mcg injection contains Teriparatide, a synthetic version of parathyroid hormone (PTH), and is used in the treatment of osteoporosis. Osteoporosis is a condition characterized by weakened bones, which significantly increases the risk of fractures. These fractures can severely impact an individual’s quality of life, leading to pain and limited mobility. Osteri 600mcg injection works by actively promoting the creation of new bone tissue and enhancing bone mineral density. This medication has also demonstrated an ability to accelerate bone healing in individuals who have sustained fractures, specifically by promoting the formation of callus, the initial new bone bridge that forms during the healing process, thereby leading to faster and more efficient recovery.
However, Osteri 600mcg injection is contraindicated in certain individuals. It should not be used by those with a known hypersensitivity or allergic reaction to Osteri 600mcg injection or any of its components. Additionally, it is not recommended for individuals with a history of skeletal malignancies, such as osteosarcoma, or those with bone metastases. If an individual has previously received radiation therapy that involved the skeleton, the use of this medication is not advised due to a potential increased risk of osteosarcoma development.

